Menu

New EO Addresses Price Transparency, Hospital Consolidation, and Drug Pricing

On July 9, 2021, the Biden Administration issued an executive order (EO), “Promoting Competition in the American Economy,” to address corporate consolidation, lack of competition and high prices for consumers, and low wages.[i] The health care portion of the EO focuses on improving competition to address health care prices and access to care in four [...] Read More

Four Drug Pricing Executive Orders Announced on Most Favored Nation, Rebates, 340B, and Drug Importation

President Trump has signed four executive orders (EOs) designed to lower prescription drug prices. This administration has repeatedly touted lowering drug prices as a priority and these orders touch on areas the administration has previously looked at including setting Medicare Part B payment based on international prices (referred to as “most favored nation”), prescription drug [...] Read More